DFS and OS according to treatment arm. (A) DFS of CR patients. Predicted 5-year DFS was 43% for the HiDAC group (n = 389; red line) and 39% for the multiagent CT group (n = 392; blue line; P = .724). (B) OS of CR patients. Predicted 5-year OS was 58% for the HiDAC group (n = 389; red line) and 56% for the multiagent CT group (n = 392; blue line; P = .954).